PriceSmart Inc. (NASDAQ: PSMT) is scheduled to report its earnings results for the third quarter of 2019 on Wednesday after the market closes. The membership-style shopping warehouse club operator’s results will be hurt by income tax provision as well as costs from omnichannel capabilities expansion.
The results are expected to be impacted by the continuation of foreign currency devaluation as well as some of the geopolitical and economic impacts arising from trade uncertainty. The company expects the new format concept, which incorporates omnichannel and an e-commerce platform, to open up additional real estate and growth opportunities in the future.
The company is beginning to achieve sales from e-commerce but at a small level at this time. PriceSmart continues to increase options for last mile delivery. PriceSmart is expected to see positive comps within its food and fresh categories as well as from soda and beverages, pet supply, seafood, and meats.
Analysts expect the company’s earnings to plunge by 24.60% to $0.46 per share while revenue will rise by 1.20% to $791.38 million for the third quarter. In comparison, during the previous year quarter, the company posted a profit of $0.61 per share on revenue of $782.2 million. The company has missed analysts’ expectations thrice in the past four quarters.
For the second quarter, PriceSmart reported a 68% jump in earnings helped by lower income taxes provision. The results were negatively impacted by costs related to investments to expand its omnichannel capabilities as well as operating results of its marketplace and casillero business. Revenue rose 2% year-over-year. Comparable net merchandise sales declined by 0.9%.
Shares of PriceSmart opened higher on Monday and is trading in the green territory on the Nasdaq. The stock has fallen over 34% in the past year and over 10% in the past three months.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
